Programme

FRIDAY 6 MAY

9.30-10.00: Introduction | D. M. Bissell, San Francisco, USA

Pointers in Liver Transplantation: Hepatitis C

10.00-10.45: Immune response to Hep C virus | P. Klenerman, Oxford, UK

10.45-11.30: Retransplantation for recurrent hepatitis C in the transplant recipient: a contraindication? | M. Berenguer, Valencia, Spain

11.30-12.00: Coffee Break

12.00-12.45: HCV disrupts BMP signalling and suppresses hepcidin. Why?| H. Drakesmith, Oxford, UK

12.45-13.30: Organ allocation: should the decision be guided by disease severity or by transplant benefit? | S. Biggins, Denver

13.30-14.30: Lunch

Pointers in Liver Transplantation: reperfusion injury, immunity and
surgery aspects

14.30-15.15: Novel targets for hepatic ischemia and reperfusion injury: Integrins and matrix metalloproteinases | A. Coito, Los Angeles

15.15-16.00: Allograft tolerance; minimizing immunosuppression | A. Sanchez-Fueyo, Barcelona

6.00-16.30: Coffee Break

16.30-17.00: The Portuguese experience in familial amyloidosis: patient and domino results | Linhares Furtado, University of Coimbra

17.00-17.30: Liver allograft pathology | Mª Augusta Cipriano, HUC, Coimbra

17.30-18.00: Hepatic transplantation in S. Antonio Hospital – Porto | Jorge Daniel, CHP, Porto

18.00 - 18.30: General

 

SATURDAY 7 MAY

Hepatocellular carcinoma

9.30-10.10: Reptin and Pontin in human hepatocellular carcinoma. Expression, role and therapeutic targeting | J. Rosenbaum, INSERM, Bordeaux

10.15-11.00: Fibrinogenesis and pancreatic cancer | Eduardo Barroso, Lisbon

11.00-11.30: Coffee Break

11.30-12.15: HCC: Natural history, and expansion of the Milan criteria | François Durand, Paris

12.15-13.00: Concluding Remarks